Skip to main content
. Author manuscript; available in PMC: 2010 Feb 16.
Published in final edited form as: Am J Physiol Renal Physiol. 2004 Jun;286(6):F1072–F1078. doi: 10.1152/ajprenal.00425.2003

Fig. 7.

Fig. 7

Effect of calphostin C (100 nM), GF-109203x (10 μM), phenylarsine oxide (PAO, 1 μM), and PAO ± PKC inhibitor on the normalized channel activity in the CCD. *Difference is significant compared with the control value (without PAO, P < 0.001).